MARCHASIA BUSINESS OUTLOOK9NEWSROOMONCARE RAISES RS. 27 CR TO EXPAND AFFORDABLE CANCER CAREShein has reported that it would invest over 10 billion yuan (around 1.5 billion US dollars) to reinforce its supply chain in Guangdong within three years.Its investment will be oriented at construction of intelligent supply chain systems and strengthening the capabilities of cross-border e-commerce in southern China.Founder Xu Yangtian mentioned the project is aimed at upgrading manufacturing efficiency and logistics infrastructure, including a US 504 million self-constructed logistics hub that will help deliveries faster.It is significant to a company that has traditionally been focused on asset-light operations and third-party logistics relationships.Headquartered in Nanjing, Shein collaborates with almost 10,000 suppliers in Guangzhou where it can provide employment to more than 600,000 people.This new investment is an indicator of a new focus on China, despite it already shifting its headquarters to Singapore and considering some external listing opportunities.This growth is among the growing external demands. The United States has already abolished its de minimis exemption on Chinese products, and the European Union is ready to introduce taxes on small packages.Simultaneously, Shein experiences deteriorating sales in the US, increasing regulatory attention, and legal liability on product safety and data security, as an operationally resilient and a swift shipping strategy has become a strategic imperative. Gurugram-based healthcare startup Oncare has raised 27 crore (US$2.96 million) in a Series A funding round led by Sky Impact Capital, with participation from Huddle Ventures, Lotus Herbal Group, Steerx, and Tremis Capital.Oncare operates oncology departments within mid-sized, non-branded hospitals and aims to expand its footprint across India. The company claims it offers chemotherapy at approximately 40% lower costs than corporate hospitals around 24,000­25,000 per session and surgeries at 30­40% lower prices. Since launch, it says it has served tens of thousands of patients.The startup plans to deploy the fresh capital toward geographic expansion and scaling its network of cancer care centers, particularly in tertiary cities across Uttar Pradesh, Bihar, and West Bengal.Its model is built on pooled procurement, combining drug orders across partner hospitals to reduce per-unit costs. This approach addresses a key challenge: many mid-sized hospitals purchase high-cost oncology drugs individually, limiting bargaining power and raising patient costs.India's National Cancer Grid previously negotiated drug procurement for 23 centers, achieving median savings of 82% versus maximum retail prices. Lower prices are critical, as studies show a standard early-stage HER2+ breast cancer regimen can cost nearly 10 years of average annual wages in India.By embedding specialist oncology services within existing hospitals, Oncare aims to reduce travel and accommodation burdens for patients outside major metros potentially creating a scalable model for other complex medical services. SHEIN ANNOUNCES $1.5B CHINA EXPANSION PLANKey Highlights· Shein to invest $1.5 billion in supply chain expansion in Guangdong over three years.· Investment includes a $504 million self-built logistics hub to speed up deliveries.· Move signals renewed China focus amid tariff pressures and IPO plans.Key Highlights· Oncare raises 27 crore in Series A to expand oncology network· Claims chemotherapy costs 40% lower than corporate hospitals· Targets Tier 2 and Tier 3 cities to improve cancer care access
< Page 8 | Page 10 >